<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-62KMTIDY/548ce492-9778-49ca-979b-81d0c8a1fd1d/PDF"><dcterms:extent>318 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-62KMTIDY/788b1ef3-e02a-4d3a-a217-535cf002768c/TEXT"><dcterms:extent>32 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-62KMTIDY"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2017</dcterms:issued><dc:creator>Gašperlin, Mirjana</dc:creator><dc:creator>Zvonar Pobirk, Alenka</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:68</dc:format><dc:format xml:lang="sl">str. 115-122</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID_HOST:4334705</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-62KMTIDY</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">farmacevtske oblike</dc:subject><dc:subject xml:lang="sl">fiksne kombinacije učinkovin</dc:subject><dc:subject xml:lang="sl">mesto aplikacije</dc:subject><dc:subject xml:lang="sl">orodisperzibilne oblike</dc:subject><dc:subject xml:lang="sl">pogostost odmerjanja</dc:subject><dc:subject xml:lang="sl">prirejeno sproščanje</dc:subject><dc:subject xml:lang="sl">starostniki</dc:subject><dc:subject xml:lang="sl">transdermalni obliži</dc:subject><dc:subject xml:lang="sl">večenotne oblike</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q7649708" /><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Starostnikom prijazne farmacevtske oblike| Older patients friendly dosage forms|</dc:title><dc:description xml:lang="sl">An increasing elderly population (people older than 65 years) is leading to a change in global demographics. This presents a new challenge to society and the pharmaceutical industry. For achieving optimal therapeutic effect it is thus essential to focus on developing older patient friendly dosage forms with the particular attention given to the specific physical limitations (e.g. swallowing difficulties, the loss of visual acuity, strength and dexterity), cognitive capabilities (e.g. memory impairment, (un)ability of understanding product use and dosing regimen) and overall health conditions of target patient population. In the present article a review of classical and novel delivery systems for oral, oromucosal, (trans)dermal, parenteral and ophthalmic application focusing on older patient friendly dosage forms is given</dc:description><dc:description xml:lang="sl">V razvitem svetu narašča delež starejše populacije, to so ljudje starejši od 65 let, kar spreminja globalno demografsko sliko in predstavlja nove izzive tako družbi kot farmacevtski industriji. Za doseganje čim boljših izidov zdravljenja je bistven razvoj starostnikom prijaznih farmacevtskih oblik, pri načrtovanju katerih moramo nujno upoštevati fizične omejitve (npr. nezmožnost požiranja, slabši vid ter zmanjšanje gibljivosti in fizične moči), kognitivne omejitve (npr. slabši spomin, nerazumevanje načina uporabe farmacevtskih oblik) in splošno zdravstveno stanje posameznikov. V članku je podan pregled klasičnih in novejših (per)oralnih, (trans)termalnih, parenteralnih FO ter FO za aplikacijo v oko, ki jih lahko opredelimo kot starostnikom prijazne</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-62KMTIDY"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-62KMTIDY" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-62KMTIDY/548ce492-9778-49ca-979b-81d0c8a1fd1d/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-62KMTIDY/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-62KMTIDY" /></ore:Aggregation></rdf:RDF>